Our opinion on the current state of DIS-CHEM(DCP)Dis-Chem Pharmacies (DCP) listed in November 2016 and competes directly with Clicks (CLS) in the pharmaceutical, medicine, and beauty products markets. It is a family business run by the Saltzman family, who had a controlling stake in the business through a private company, Ivlyn. On 24th August 202
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1 ZAR
984.48 M ZAR
36.28 B ZAR
480.11 M
About DIS-CHEM PHARMACIES LTD
Sector
Industry
CEO
Rui Manuel Morais
Website
Headquarters
Midrand
Founded
1978
ISIN
ZAE000227831
FIGI
BBG00F0RB5H4
Dis-Chem Pharmacies Ltd. manufactures and retails pharmaceutical products. It operates through the Retail; and Wholesale segments. The Retail segment consists of Dis-Chem stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment refers to the CJ Wholesale and Dis-Chem Distribution businesses, wholesalers of pharmaceutical and a variety of health and beauty products. The company was founded by Ivan Leon Saltzman and Lynette Frances Saltzman in 1978 and is headquartered in Midrand, South Africa.
Our opinion on the current state of DIS-CHEM(DCP)Dis-Chem Pharmacies (DCP), which listed in November 2016, is a prominent competitor to Clicks (CLS) in the pharmaceutical, medicine, and beauty products markets. The business is led by the Saltzman family, with a significant stake held through a private company, Ivlyn. In August 2021, Ivlyn announce
$JSEDCP - Dischem: Defiant, But For How Much Longer?See link below for previous analysis
The wave structure has not changed but i have made a slight adjustment to the ending diagonal wave count to cater for more upside potential seeing that the MACD has broken above the divergence trendline.
Ending Diagonals can reverse aggressively so again, lock
Our opinion on the current state of DIS-CHEM(DCP)Dis-Chem Pharmacies (DCP) listed in November 2016 and competes directly with Clicks (CLS) in the pharmaceutical, medicine, and beauty products markets. It is a family business run by the Saltzman family, who had a controlling stake in the business through a private company, Ivlyn. On 24th August 202
$JSEDCP - Dischem: Ending Diagonal & Loss of Momentum CautionSee link below for previous analysis.
Dischem is still trading in the fifth and final wave of the advance from May 2023.
Wave is unfolding as an ending diagonal pattern and has surpassed the previous target of 3300 cps.
There is also a clear loss of momentum in the stock as new highs have not bee
Our opinion on the current state of DCPDis-Chem Pharmacies, listed since November 2016, directly competes with Clicks in the pharmaceutical, medicine, and beauty products markets. Originally a family business controlled by the Saltzman family through Ivlyn, it saw a significant change in August 2021 when Ivlyn sold a portion of its stake
$JSEDCP - Dischem: Great Run, But I Count Five WavesSee link below for previous analysis.
Dischem has had a stellar run from the 2154 low, tracing out a textbook five wave advance.
Wave is a leading diagonal followed by wave which unfolded as a complex zig zag with a b-wave triangle; wave is a strong impulse and wave is a simple zig zag.
Wave
DCP: some upside potential?A price action above 3000 supports a bullish trend direction.
Crossing above 3100 triggers the option to increase long exposure.
The target price is set at 3200.
The stop-loss price is set at 2800.
Remains in an inclining channel pattern.
As long as the price action remains above its 23.6% Fibonacc
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of DCP is 3,129 ZAC — it has increased by 0.93% in the past 24 hours. Watch DIS-CHEM PHARMACIES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on JSE exchange DIS-CHEM PHARMACIES LTD stocks are traded under the ticker DCP.
DCP stock has risen by 3.93% compared to the previous week, the month change is a 0.58% rise, over the last year DIS-CHEM PHARMACIES LTD has showed a 0.94% increase.
We've gathered analysts' opinions on DIS-CHEM PHARMACIES LTD future price: according to them, DCP price has a max estimate of 4,440.00 ZAC and a min estimate of 2,900.00 ZAC. Watch DCP chart and read a more detailed DIS-CHEM PHARMACIES LTD stock forecast: see what analysts think of DIS-CHEM PHARMACIES LTD and suggest that you do with its stocks.
DCP stock is 1.86% volatile and has beta coefficient of 0.68. Track DIS-CHEM PHARMACIES LTD stock price on the chart and check out the list of the most volatile stocks — is DIS-CHEM PHARMACIES LTD there?
Today DIS-CHEM PHARMACIES LTD has the market capitalization of 26.71 B, it has increased by 4.71% over the last week.
Yes, you can track DIS-CHEM PHARMACIES LTD financials in yearly and quarterly reports right on TradingView.
DIS-CHEM PHARMACIES LTD is going to release the next earnings report on May 30, 2025. Keep track of upcoming events with our Earnings Calendar.
DCP net income for the last half-year is 577.71 M ZAR, while the previous report showed 483.56 M ZAR of net income which accounts for 19.47% change. Track more DIS-CHEM PHARMACIES LTD financial stats to get the full picture.
DIS-CHEM PHARMACIES LTD dividend yield was 1.50% in 2023, and payout ratio reached 39.86%. The year before the numbers were 1.72% and 40.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 18, 2025, the company has 20.56 K employees. See our rating of the largest employees — is DIS-CHEM PHARMACIES LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIS-CHEM PHARMACIES LTD EBITDA is 3.15 B ZAR, and current EBITDA margin is 8.16%. See more stats in DIS-CHEM PHARMACIES LTD financial statements.
Like other stocks, DCP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIS-CHEM PHARMACIES LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIS-CHEM PHARMACIES LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIS-CHEM PHARMACIES LTD stock shows the neutral signal. See more of DIS-CHEM PHARMACIES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.